Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Abatacept to Treat Refractory Sarcoidosis (STAR)

This study has been terminated.
(Funding has been pulled)
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Chicago Identifier:
First received: August 20, 2008
Last updated: June 10, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)